Skip to main content
FTH
NASDAQ Life Sciences

Faeth Posts $20.4M Q3 Loss, Cash at $174.8M Ahead of Year-End PIKTOR Data

Tom Rudovsky · Reported by BusinessWire
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$19.23
Mkt Cap
$496.911M
52W Low
$7.45
52W High
$42.143
52W Position info
158% above low
Off High info
54% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

FTH has more than doubled off its 52-week low of $7.45.

Summary

Faeth reported a Q3 2026 net loss of $20.4 million, or $0.79 per share, versus a $4.6 million loss a year earlier, as R&D jumped to $11.7 million from $2.5 million and G&A rose to $10.4 million from $2.3 million. Cash, cash equivalents and marketable securities stood at $174.8 million on September 30, 2026, up from $21.2 million at year-end 2025 — a substantial runway cushion for a company this size. The quarter's news flow was mostly already public: the FDA Fast Track designation for PIKTOR plus paclitaxel in biomarker-selected endometrial cancer (reported in August) and the board additions of Karen Vousden and Adam Schayowitz (disclosed in September and October 8-Ks). The real swing factor is the Phase 2 PIK-201 topline data in second-line advanced endometrial cancer, guided to year-end 2026, with initial PIK-101 breast cancer data pushed to 2027. Watch the PIK-201 readout — that binary event, not this quarter's burn, is what sets the stock's direction.

At the time of this announcement, FTH was trading at $19.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $496.9M. The 52-week trading range was $7.45 to $42.14. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

FTH - Latest Insights

FTH
Nov 16, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $10.50
Real-time Price: $8.70 info
Change: -$1.80 (-17%) info
Market Cap: $224.842M info
FTH
Nov 09, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $8.70 info
Change: -$13.80 (-61%) info
Market Cap: $224.842M info
FTH
Nov 03, 2026, 8:10 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $19.20
Real-time Price: $8.70 info
Change: -$10.50 (-55%) info
Market Cap: $224.842M info
FTH
Aug 17, 2026, 7:31 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $32.44
Real-time Price: $8.70 info
Change: -$23.74 (-73%) info
Market Cap: $224.842M info
FTH
Aug 04, 2026, 7:40 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $30.00
Real-time Price: $8.70 info
Change: -$21.30 (-71%) info
Market Cap: $224.842M info